Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03209830
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT03209830
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Norway
- Registry status
- Completed
Technical summary
Registry record NCT03209830. Randomized; double masking; primary purpose treatment. Start 2017-09-05 (actual); primary completion 2019-09-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug)
- OSU 6162
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- Oslo University Hospital
- Collaborator
- Göteborg University
- Collaborator
- Sahlgrenska University Hospital
Record details
- Record id
cardio:ct-nct03209830- Content hash
1ebf411e81afc26f86676e35f89e84adadaa5b15f9faab4e9715dca4bb687d51